Peer M Portner, PhD, Piet G

Slides:

Advertisements

Similar presentations

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Advertisements

Left ventricular assist system as a bridge to myocardial recovery

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Left ventricular assist system as a bridge to myocardial recovery

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Outcomes of Reintervention on the Autograft After Ross Procedure

Laura Harvey, MD, Christopher Holley, MD, Samit S

Dhaval Chauhan, MD, Alexis K

Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device Roland Hetzer, MD, PhD, Johannes Müller, MD, Yuguo Weng,

CTSNet: a unique educational vehicle

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Shahrokh.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Mitral commissurotomy, a technique outdated

Javed Butler, MD, Carrie Geisberg, MD, Renee Howser, MSN, Peer M

Age-Related Outcomes of the Ross Procedure Over 20 Years

Long-Term Outcomes of the Mosaic Bioprosthesis

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Durability of Homografts Used to Treat Complex Aortic Valve Endocarditis Willem Flameng, MD, PhD, Willem Daenen, MD, Ramadan Jashari, MD, Paul Herijgers,

Mariano Garcı́a-Yuste, MD, José M

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Late outcomes of open heart surgery in patients 70 years or older

Ventricular assist device programs: design and function

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Atrioventricular valve regurgitation in patients with single ventricle: impact of the bidirectional cavopulmonary anastomosis William T Mahle, MD, Meryl.

Michael W. A. Chu, MD, Katie L. Losenno, MD, MSc, Luc A

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Erik N. Sorensen, PhD, Richard N. Pierson, MD, Erika D

Editorial Board, January 2010

William M. Whited, MD, Paul Henley, BS, Erin M

Pulmonary Homograft Monocusp Reconstruction of the Right Ventricular Outflow Tract: Outcomes to the Intermediate Term Dilip S. Nath, MD, Daniel P. Nussbaum,

Optimal Timing for Elective Early Primary Repair of Tetralogy of Fallot: Analysis of Intermediate Term Outcomes Michael E.A. Cunningham, MD, Mary T.

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Role of transvalvular gradient in outcome from valve replacement for aortic stenosis Arjuna Weerasinghe, FRCS, PhD, Merangani Yusuf, FRCS, Thanos Athanasiou,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Kiyotaka Fukamachi, MD, PhD, Patrick.

Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.

Favorable Results of Implantable Cardioverter-Defibrillator Implantation in Patients Older Than 70 Years Kara J Quan, Jai H Lee, Otto Costantini, Anastasios.

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Late incidence and determinants of stroke after aortic and mitral valve replacement Marc Ruel, MD, MPH, Roy G Masters, MD, Fraser D Rubens, MD, Pierre.

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction John Alfred Carr, MD, Benjamin E Haithcock,

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Joseph S Coselli, MD, Lori D Conklin, MD, Scott A LeMaire, MD

Minimally invasive resection of mediastinal parathyroid adenomas

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Cerebral and Systemic Embolization During Left Ventricular Support With the Novacor N100 Device Christof Schmid, MD, Michael Weyand, MD, Darius G Nabavi,

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi Edimar Alcides Bocchi, MD, Alfredo Fiorelli,

Presentation transcript:

Improved outcomes with an implantable left ventricular assist system: a multicenter study Peer M Portner, PhD, Piet G.M Jansen, MD, Philip E Oyer, MD, Dereck R Wheeldon, PhD, Narayanan Ramasamy, PhD The Annals of Thoracic Surgery Volume 71, Issue 1, Pages 205-209 (January 2001) DOI: 10.1016/S0003-4975(00)02514-5

Fig 1 Inflow conduits at explant. Gross photography of longitudinally sectioned Cooley (A) and Vascutek (B) conduits, from a 17 year old supported for 61 days and an 18 year old supported for 99 days, respectively, both male with idiopathic cardiomyopathy and both successfully transplanted. Note the retracted, nonadherent pannus on the explanted Cooley conduit and the smooth adherent pannus lining the Vascutek conduit. The Annals of Thoracic Surgery 2001 71, 205-209DOI: (10.1016/S0003-4975(00)02514-5)

Fig 2 Freedom from embolic CVA. Freedom from embolic CVA was computed using the Kaplan-Meier algorithm. During the observation period (180 days post-LVAS implantation), the risk of embolic CVA was significantly lower in the test group (p = 0.022, log-rank statistic). The number of patients at risk (control, test) were 204, 139 at 1 month; 157, 106 at 2 months; 95, 79 at 4 months; and 64, 36 at 6 months. The Annals of Thoracic Surgery 2001 71, 205-209DOI: (10.1016/S0003-4975(00)02514-5)